U.S., Sept. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07811362) titled 'CRPS-RISE Outcomes Registry' on Aug. 31.
Brief Summary: The goal of this observational study is to learn about how well neridronate keeps working in the months after treatment. For 12 or up to 24 months while the registry is open participants will answer online survey questions about their CRPS pain, medication use or procedures done and how CRPS affects what they are able to do.
Study Start Date: Sept. 16
Study Type: OBSERVATIONAL
Condition:
Complex Regional Pain Syndrome I (CRPS I)
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Ambros Therapeutics, Inc.
Disclaimer: Curated by HT Syndication....